Switzerland buys Pfizer's COVID-19 antiviral Paxlovid

Switzerland signed a contract to buy Pfizer's anti-viral drug Paxlovid to treat Covid-19, it said on Friday.

The European country said it had signed a contract to buy 12,000 packages and the first treatments for certain at-risk patients would start this month.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)